Bristol-Myers Squibb
BMY • NYSE
Bristol-Myers Squibb is a drug manufacturers - general company in the healthcare sector trading on NYSE, led by CEO Christopher S. Boerner, with a market cap of $123.53B.
CEOChristopher S. Boerner
Market Cap$123.53B
Drug Manufacturers - General
Healthcare
Employees34.1K
Websitebms.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Bristol-Myers Squibb
Date
Thursday, April 23, 2026 (in 2 months)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$1.44
Revenue Estimate
$10.8B
Earnings History
Past 12 earnings reports for Bristol-Myers Squibb
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 5, 2026 | Q4 2025 | $1.26Est: $1.19 | +5.9% | $12.5BEst: $12.3B | +1.9% | — |
| Oct 30, 2025 | Q3 2025 | $1.63Est: $1.51 | +7.9% | $12.2BEst: $11.8B | +3.5% |  10-Q |
| Jul 31, 2025 | Q2 2025 | $1.46Est: $1.15 | +27.0% | $12.3BEst: $11.4B | +8.0% | 10-Q |
| Apr 24, 2025 | Q1 2025 | $1.80Est: $1.49 | +20.8% | $11.2BEst: $10.7B | +4.8% | 10-Q |
| Feb 6, 2025 | Q4 2024 | $1.67Est: $1.47 | +13.6% | $12.3BEst: $11.6B | +6.8% | 10-K |
| Oct 31, 2024 | Q3 2024 | $1.80Est: $1.49 | +20.8% | $11.9BEst: $11.3B | +5.4% | 10-Q |
| Jul 26, 2024 | Q2 2024 | $2.07Est: $1.63 | +27.0% | $12.2BEst: $11.6B | +5.6% | 10-Q |
| Apr 25, 2024 | Q1 2024 | -$4.40Est: -$4.44 | +0.9% | $11.9BEst: $11.5B | +3.5% | 10-Q |
| Feb 2, 2024 | Q4 2023 | $1.70Est: $1.53 | +11.1% | $11.5BEst: $11.2B | +2.5% | 10-K |
| Oct 26, 2023 | Q3 2023 | $2.00Est: $1.76 | +13.6% | $11.0BEst: $11.0B | -0.0% | 10-Q |
| Jul 27, 2023 | Q2 2023 | $1.75Est: $1.98 | -11.6% | $11.2BEst: $11.8B | -4.9% | 10-Q |
| Apr 27, 2023 | Q1 2023 | $2.05Est: $1.97 | +4.1% | $11.3BEst: $11.5B | -1.3% | — |